Skip to main content

Layout of SPARC components, use hyperlinks to navigate


Translational Partnerships for Human Functional Mapping and New Indications

SPARC3 supports translational partnerships between industry and SPARC investigators to produce proofs of concept for new nerve stimulation indications and to study functional neuromodulation in the context of human clinical studies.

SPARC 3 facilitates these partnerships, through template agreements and leveraging NIH Common Fund support. Moreover, data from these studies may be helpful when integrated with information generated by the Anatomical and Functional Mapping component and the Next Generation Tools and Technologies component.

Graphic illustration of schematic for FDA device approval pathways.

Schematic for FDA device approval pathways

View SPARC3 funded research here.

This page last reviewed on February 5, 2024